Skip to main content
. 2016 Jul 1;30(8):1039–1044. doi: 10.1038/eye.2016.122

Table 1. Demographic and clinical data of our study sample.

  Non-IFIS group (n=1211) IFIS group (n=63) P-value
  Mean±SD  
Age (years) 71.8±9.2 73.3±6.1 0.219a
Axial length (mm) 23.7±1.4 22.3±1.8 0.027a
  N (%)  
Male sex 642 (53.0) 47 (74.6) <0.001b
Hypertension 812 (67.1) 51 (81.0) 0.031b
Diabetes mellitus 184 (15.2) 11 (17.5) 0.592b
Pseudoexfoliation 233 (19.2) 13 (20.6) 0.745c
Glaucoma 127 (10.5) 8 (12.7) 0.531c
Retinal disorders 153 (12.6) 6 (9.5) 0.561c
Tamsulosin use 117 (9.7) 18 (28.6) <0.001c
Alfuzosin use 109 (9.0) 12 (19.0) 0.014c
Terazosin use 49 (4.0) 6 (9.5) 0.050c
Benzodiazepine use 103 (8.5) 11 (17.5) 0.023c
Finasteride use 59 (4.9) 8 (12.7) 0.015c
Rivastigmine use 3 (0.2) 2 (3.2) 0.022c
Quetiapine use 8 (0.7) 3 (4.8) 0.014c
Warfarin/aspirin use 265 (21.9) 19 (30.2) 0.123c

Abbreviations: IFIS, intraoperative floppy iris syndrome; SD, standard deviation.

a

P-value derived from Mann–Whitney–Wilcoxon test for independent samples.

b

P-value derived from χ2-test.

c

P-value derived from Fisher's exact test. Bold cells denote statistical significance.